Protagonist Appoints William D. Waddill To Board
Protagonist Therapeutics has appointed William D. Waddill, who is currently senior vice president (SVP) and chief financial officer (CFO) of Calithera Biosciences, to Protagonist’s board of directors. Before Calithera, Waddill was SVP and CFO at OncoMed Pharmaceuticals and prior to this he was SVP and CFO at Ilypsa. Before Ilypsa, he was the founder and principal at Square One Finance.
You may also be interested in...
The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.
Plus Sanofi and Translate Bio release preclinical data from their COVID-19 vaccine candidate, another entrant to the now crowded mRNA vaccine field.